Noblett Karen's Form 4 filing
Axonics, Inc. (AXNX) · filed Feb 3, 2022
- Accession no.
- 0001562180-22-001109
- Filed
- Feb 3, 2022
- Trade date
- Jan 31-Feb 3, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $322.4K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Noblett KarenCIK 0001756240 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Common Stock | AGrant or awardAcquired | +5,350 | $0.00 | $0 | 42,803 | Direct | |
| Feb 3, 2022 | Common Stock | MOption exerciseAcquired | +19,463 | $0.00 | $0 | 62,266 | Direct | |
| Feb 3, 2022 | Common Stock | SSaleDisposed | −6,343 | $48.21F3 | −$305,796.03 | 55,923 | Direct | |
| Feb 3, 2022 | Common Stock | SSaleDisposed | −339 | $49.03F4 | −$16,621.17 | 55,584 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Common Stock | AGrant or awardAcquired | +4,250 | $0.00 | $0 | 4,250 | Direct | |
| Jan 31, 2022 | Common Stock | AGrant or awardAcquired | +3,250 | $0.00 | $0 | 3,250 | Direct | |
| Feb 3, 2022 | Common Stock | MOption exerciseDisposed | −5,333 | $0.00 | $0 | 0 | Direct | |
| Feb 3, 2022 | Common Stock | MOption exerciseDisposed | −14,130 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.